FDA warns against using kratom for opioid addiction

IN -

IN—(Reuters) - The U.S. Food and Drug Administration warned on Tuesday about the usage of kratom, citing reports of 36 deaths, and said there is no reliable evidence to support its use to treat opioid withdrawal symptoms.

FDA warns against using kratom for opioid addiction. The FDA waded into the debate over the safety of kratom, a botanical substance that advocates say can help reduce symptoms of opioid withdrawal.